Anita Dushyanth
Stock Analyst at Berenberg
(0.95)
# 3,037
Out of 4,667 analysts
4
Total ratings
66.67%
Success rate
-2.47%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $11.45 | +74.67% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $6.03 | +115.59% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $75 | $0.59 | +12,655.10% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $17.03 | +446.10% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $11.45
Upside: +74.67%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $6.03
Upside: +115.59%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $75
Current: $0.59
Upside: +12,655.10%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $17.03
Upside: +446.10%